Cornell University, College of Veterinary Medicine, Department of Clinical Sciences, Ithaca, New York, USA.
University of Washington, Department of Immunology, Seattle, Washington, USA.
Am J Sports Med. 2023 Mar;51(4):1047-1058. doi: 10.1177/03635465231153588. Epub 2023 Feb 16.
Infiltration of cluster of differentiation (CD) 3 (CD3) T cells into the synovium and synovial fluid occurs in most patients with posttraumatic osteoarthritis. During disease progression, proinflammatory T helper 17 cells and anti-inflammatory regulatory T cells infiltrate the joint in response to inflammation. This study aimed to characterize the dynamics of regulatory T and T helper 17 cell populations in synovial fluid from equine clinical patients with posttraumatic osteoarthritis to determine whether phenotype and function are associated with potential immunotherapeutic targets.
An imbalance of the ratio of regulatory T cells and T helper 17 cells would be associated with disease progression in posttraumatic osteoarthritis, suggesting opportunities for immunomodulatory therapy.
Descriptive laboratory study.
Synovial fluid was aspirated from the joints of equine clinical patients undergoing arthroscopic surgery for posttraumatic osteoarthritis resulting from intra-articular fragmentation. Joints were classified as having mild or moderate posttraumatic osteoarthritis. Synovial fluid was also obtained from nonoperated horses with normal cartilage. Peripheral blood was obtained from horses with normal cartilage and those with mild and moderate posttraumatic osteoarthritis. Synovial fluid and peripheral blood cells were analyzed by flow cytometry, and native synovial fluid was analyzed by enzyme-linked immunosorbent assay.
CD3 T cells represented 81% of lymphocytes in synovial fluid, which increased in animals with moderate posttraumatic osteoarthritis to 88.3% ( = .02). CD14 macrophages were doubled in those with moderate posttraumatic osteoarthritis compared with mild posttraumatic osteoarthritis and controls ( < .001). Less than 5% of CD3 T cells found within the joint were forkhead box P3 protein (Foxp3) regulatory T cells, but a 4- to 8-times higher percentage of nonoperated and mild posttraumatic osteoarthritis joint regulatory T cells secreted interleukin (IL)-10 than peripheral blood Tregs ( < .005). T regulatory-1 cells that secreted IL-10 but did not express Foxp3 accounted for approximately 5% of CD3 T cells in all joints. T helper 17 cells and Th17-like regulatory T cells were increased in those with moderate posttraumatic osteoarthritis ( < .0001) compared with mild and nonoperated patients. IL-10, IL-17A, IL-6, chemokine (C-C motif) ligand (CCL) 2 (CCL2), and CCL5 concentrations detected by enzyme-linked immunosorbent assay in synovial fluid were not different between groups.
An imbalance of the ratio of regulatory T cells and T helper 17 cells and an increase in T helper 17 cell-like regulatory T cells in synovial fluid from joints with more severe disease provide novel insights into immunological mechanisms that are associated with posttraumatic osteoarthritis progression and pathogenesis.
Early and targeted use of immunotherapeutics in the mitigation of posttraumatic osteoarthritis may improve patient clinical outcomes.
在大多数创伤后骨关节炎患者中,CD3(CD3)T 细胞浸润到滑膜和滑液中。在疾病进展过程中,炎症反应会导致促炎辅助性 T 细胞 17(Th17)细胞和抗炎调节性 T 细胞浸润关节。本研究旨在描述创伤后骨关节炎临床患者滑液中调节性 T 和 Th17 细胞群的动态变化,以确定表型和功能是否与潜在的免疫治疗靶点相关。
调节性 T 细胞和 Th17 细胞比例失衡与创伤后骨关节炎的进展有关,提示有机会进行免疫调节治疗。
描述性实验室研究。
对接受关节镜手术治疗创伤后骨关节炎的临床患者关节进行滑液抽吸,这些患者的创伤后骨关节炎是由关节内碎片引起的。将关节分为轻度或中度创伤后骨关节炎。还从非手术的正常软骨关节中获得滑液。从正常软骨、轻度和中度创伤后骨关节炎的马中获得外周血。通过流式细胞术分析滑液和外周血细胞,并通过酶联免疫吸附试验分析天然滑液。
CD3 T 细胞占滑膜液淋巴细胞的 81%,中度创伤后骨关节炎动物的 CD3 T 细胞增加到 88.3%(=0.02)。与轻度创伤后骨关节炎和对照组相比,中度创伤后骨关节炎的 CD14 巨噬细胞增加了一倍(<0.001)。关节内发现的不到 5%的 CD3 T 细胞是叉头框 P3 蛋白(Foxp3)调节性 T 细胞,但非手术和轻度创伤后骨关节炎关节调节性 T 细胞分泌白细胞介素(IL)-10 的比例比外周血 Tregs 高 4-8 倍(<0.005)。分泌 IL-10 但不表达 Foxp3 的 T 调节-1 细胞约占所有关节中 CD3 T 细胞的 5%。与轻度和非手术患者相比,中度创伤后骨关节炎患者 Th17 细胞和 Th17 样调节性 T 细胞增加(<0.0001)。通过酶联免疫吸附试验检测到的滑膜液中 IL-10、IL-17A、IL-6、趋化因子(C-C 基序)配体(CCL)2(CCL2)和 CCL5 浓度在各组之间无差异。
滑液中调节性 T 细胞与 Th17 细胞比例失衡以及 Th17 样调节性 T 细胞增加,提示与创伤后骨关节炎进展和发病机制相关的免疫机制有新的认识。
早期和有针对性地使用免疫疗法来减轻创伤后骨关节炎可能会改善患者的临床预后。